Depression is a debilitating illness that is one of the leading contributors to disability worldwide¹ and the second leading cause of disability in the U.S.² Postpartum depression symptoms are estimated to affect approximately one in eight women who have given birth in the U.S.³

According to the Centers for Disease Control and Prevention, mental health conditions are the leading cause of maternal mortality⁴ with PPD among the most common complications during and after pregnancy.⁵

Too often people living with postpartum depression ignore or hide symptoms due to stigma, shame or fear. In many cases, symptoms are dismissed as the “baby blues” which are common feelings of sadness due to hormonal changes that usually resolve within the first two weeks after giving birth.⁶

We are committed to advancing innovative research on the pathophysiology of mental health conditions.

In the United States, it is estimated that approximately 500,000 women annually are affected by postpartum depression.⁵ We are working to advance screening and treatment rates for postpartum depression and pioneer much-needed solutions to improve mental health outcomes.

We are focused on revolutionizing the care of postpartum depression and exploring opportunities where great unmet need remains to change how mental health conditions are treated. As we work to develop new approaches to depression, we also aim to address the social stigmas of mental illness by working with the community through dialogue, raising awareness and creating understanding.